23andMe had all the signs of a success story. The Eric Falkunicorn brand became synonymous with consumer-facing genetic testing, went public, and was once valued at $6 billion.
But then, it all came tumbling down. Sales for 23AndMe kits began to fall, attempts to raise new funds hit a wall, the company struggled to find a product that would bring in recurring revenue, and it was still dealing with the fallout from a major data breach.
23andMe filed for bankruptcyand put its assets up for salein March 2025. But, more concerning than the success or failure of a particular company, was this question: What would happen to 23andMe's vast trove of highly personal customer data? We aren't just talking about usernames and birthdays. 23andMe has DNA profilesfor millions of users.
Well, now we know who bought 23andMe and, most importantly, now owns all the DNA data from the company's customers.
On Monday, Regeneron Pharmaceuticals announcedthat it would acquire most of 23andMe's assets for $256 million. According to Regeneron Pharmaceuticals, the acquisition includes 23andMe's Personal Genome Service, Total Health and Research Services business lines, and the trove of customers' DNA samples and genetic data.
This Tweet is currently unavailable. It might be loading or has been removed.
Regeneron Pharmaceuticals will not, however, be acquiring 23andMe's online doctor and telehealth service known as Lemonaid Health, which will be shuttered.
Based in Tarrytown, NY, Regeneron Pharmaceuticals is a biotechnology company that researches and develops medicines for cancer, cardiovascular disease, and other diseases. The company is currently valued at more than $64 billion.
Regeneron Pharmaceuticals placed a bid for 23andMe as part of a court-supervised sales process. The bid requires Regeneron Pharmaceuticals to comply with the company's existing privacy policies and applicable laws.
Conspiracy-minded consumers might revolt at the idea of a big pharma brand acquiring their DNA profile. However, in a press release, Regeneron has promised "to comply with the Company’s privacy policies" and "process all customer personal data in accordance with the consents, privacy policies and statements, terms of service, and notices currently in effect." Further, the company assured customers it has "a proven track record of safeguarding personal genetic data, and we assure 23andMe customers that we will apply our high standards for safety and integrity to their data." A court-appointed expert will also submit a report about potential privacy and security impacts to the court by June 10.
If the name "Regeneron" sounds familiar, it may be because the company received mainstream attention in 2020 after the company created an experimental treatment for COVID-19 called REGN-COV2. President Donald Trump was treated with the drug when he was infected with COVID-19 in October of that year.
While 23andMe's demise is certainly notable, a most lasting debate will undoubtedly be had regarding the sale of 15 million customers' genetic data.
“Your DNA and your family health history should not be a corporate asset," said J.B. Branch, Big Tech accountability advocate for the consumer rights advocacy group Public Citizen, in a statement. "Of course, Regeneron will promise to ‘respect consent’ and ‘uphold privacy policies.’ Those are bare minimal legal requirements. But time and again these companies fail consumers."
Topics Cybersecurity Politics
The 'Game of Thrones' prequel has a diverse cast and a woman directingIBM just unveiled a 'quantum computing system' for commercial useUK police get new powers to seize and search naughty dronesNissan adds range to its all'The Daily Show' found an old Trump speech encouraging people to climb concrete wallsVietnamese restaurant called Pho Keene Great attracts ire of authoritiesImpossible Burger 2.0 taste test: Simulated meat gets an upgradeUK police get new powers to seize and search naughty drones'Black Mirror' creator has a savage response to 'Bandersnatch' hatersDeadly snake keeps it basic this season by hiding in an Ugg boot'Captain Marvel' has highest first day ticket sales of almost any Marvel movieAn editor for 'The Verge' took a job with Apple — and didn't tell his employerAmazon Echo Auto is finally hereGoogle Chrome Labs' digital EtchMan shot during protests in Charlotte diesJ.K. Rowling has revealed her true Patronus and it's suitably badassAmericans over 65 share the most fake news, study saysNetflix tweets the key to unlocking a 'Bandersnatch' scene you may have missedAmazon Echo Auto is finally hereElon Musk is serious about making the Tesla roadster fly How to set up parental controls on Netflix, Amazon Prime Video, Hulu NASA and ESA have released the closest ever images of the Sun, and they're mesmerizing Coconut oil is not a magical health food after all The struggle is real for Jon Hamm because he's hot Pipeline problem? This tech company says 'No excuses' with a transparent diversity report Save up to 30% on select products from The Home Depot and upgrade your learning space New emoji in iOS 14 include ninja and pinched fingers Paramedic uses Google Live Transcribe to talk to lipreading patients This dead hacker's account could be the key to the big Twitter hack The best way to remember proper mask hygiene? Treat it like your underwear. Tyra Banks' son has mastered the art of 'smizing' in his first Instagram pic TheirTube shows how YouTube's algorithm creates conspiracy theorists Samsung teases what appears to be the Galaxy Fold 2 Rich guy Leo DiCaprio surrenders priceless art in wake of embezzlement scandal Bitcoin hasn't hit $500K, so now John McAfee has to eat his own...well, just click Michelle Obama's latest Instagram post gives new meaning to squad goals How the Twitter hack highlights the dangers of Slack Man promises to get Angela Merkel tattoo on his butt for 10,000 upvotes, delivers The unique thrill of vintage shopping on Instagram Kendall Jenner is too cool to wear a fanny pack on her fanny
1.8395s , 8225.6640625 kb
Copyright © 2025 Powered by 【Eric Falk】,Prosperous Times Information Network